ART Fertility Clinics: Your Best Hope for the Joy Forever of Parenthood

ART Fertility Clinics
ART Fertility Clinics

Couples seeking assistance from any fertility clinic have fairly high expectations of receiving the best fertility treatment, transparency, the highest ethical standards, compassionate care, patient satisfaction, and safety.

This is where ART Fertility Clinics stand tallest as the leading global institution in Assisted Reproductive Technologies and Human Reproductive and Medicine. With the highest pregnancy rates of 70% globally, the relentless pursuit of evidence-based medicine, proprietary research, customized patient treatment protocols, technology-backed innovations, and best-in-class IVF and genetic testing laboratories backed by world-renowned clinicians, embryologists, and nursing staff at the core of this success, ART Fertility Clinics is currently positioned as one of the best IVF and Fertility Treatment Providers.

ART Principles

Stating their vision, Dr Somesh Mittal, the Chief Executive Officer, CEO of ART India, says that it is ‘to deliver the best human reproductive medicine services in the world to address the needs of their patients; Stimulating research amongst our physicians, geneticists, and embryologists, “So that we can deliver their translational research into the latest treatments; teaching and training all of our staff to achieve the highest levels of professional excellence in patient care.”

Further, their mission is ‘to become the Global Reference benchmark for clinical outcomes, patient satisfaction, research, and teaching in Human Reproduction and Genetics.’ This is principled in their core values of striving to go the extra mile for their patients. An eagerness to be the best in the field of Human Reproduction. “Curiosity to learn and improve our services. Freedom for our staff to take the initiative and to innovate. Provide Customer Delight and Appreciation of our services,” says Dr Somesh.

Telling more about ART Fertility’s offerings and aspects that make it stand out in the cutthroat competition, he says that at ART Fertility Clinics, they have designed all their medical services and protocols, patient care systems, and infrastructure on a patient-centric approach. They have achieved the highest success rates while adhering to stringent safety standards.

The below factors illustrate the key differentiators that help them achieve the best medical outcomes along with the highest levels of patient satisfaction:

*Personalized Treatment Plans – ART’s physicians focus on understanding the root cause of infertility issues and design specific treatment plans to suit patients’ needs. This includes understanding the patient’s medical history, lifestyle, and endocrine profile, doing detailed semen analysis, and Ultrasound. ART’s stimulation protocols are completely individualized based on the patient’s hormone levels and the dosages are modified during each treatment. This ensures that the ART team can harvest the maximum number of mature oocytes. “Similarly, our embryology lab scientists and technicians select the most appropriate culture media and lab techniques and tools to ensure the healthy development of the embryos,” adds Dr Somesh.

*Science and Innovation Program – ART Fertility Clinics embodies its core thesis of providing its patients with the latest proven medical technologies in the field of Human Reproduction. ART has a very wide science and innovation program wherein its clinicians are undertaking research in a diverse field of topics, including basic research, prospective clinical studies, new medical techniques that enhance outcomes, genetics, and the use of Artificial Intelligence in analyzing medical data and defining treatments based upon empirical findings. “We currently have forty-one (41) areas of active research ongoing,” informs Dr Somesh.

*Peer Reviewed Research Publications – He furthers, “At ART Fertility Clinics, we are extremely prolific in publishing our research findings in the highest-impact international journals in the field of Human Reproduction.” In their brief history of five years, Dr Somesh and his ART team have published over 72 articles in international journals, including Fertility and Sterility, Human Reproduction, Reproductive Biomedicine Online, etc. These scientific papers are peer-reviewed by leading IVF luminaries and endorse the work undertaken by our clinicians, embryologists, and geneticists.

*Experience and Well-Trained Clinical Staff Delivering the Highest Success Rates Globally – At ART Fertility Clinics, they strongly believe in evidence-based medicine, and their physicians and embryologists follow this doctrine diligently. All their clinicians and embryologists are alumni of distinguished Medical and Human Reproduction programs, including ESHRE certifications. Their training regimen is extremely rigorous and ensures that all their practitioners adhere to the highest quality standards.

At ART Fertility Clinics, they have achieved the highest success rates (pregnancy rates of 70% globally) and have become international referral clinics attracting patients from all over the world. “Our clinicians understand the underlying reasons for recurrent miscarriages and can successfully treat patients with multiple failed IVF cycles,” he states.

*Independent, Third-Party Audits to Ensure Quality Standards and Success Rates Claims – At ART Fertility clinics, they assign an independent third party to undertake a comprehensive audit of their Clinical work including the embryology lab to ensure adherence to high standards and continuous improvements. “These auditors validate our Success rates to ensure there is no bias or misrepresentations in our published success rates,” he shares.  

*State of the ART Infrastructure – At ART Fertility Clinics, they have designed the most efficient facility layouts to ensure patient safety and the best medical outcomes. They have invested in the latest and most technologically advanced infrastructure, including incubators, Microscopes, Next Generation Sequencer, OR equipment and Tools, the Air Handling Unit that ensures a healthy environment for growing the embryos, 4-Dimensional Ultrasound M/Cs, the RI Witness system to ensure there is no mixing of oocytes/sperms amongst patients and an electronic alarm system that is fitted with sensors at all ART Labs to continuously monitor the temperature, humidity, gases associated with key equipment.

*Ethics and Transparency in Treatment and Pricing – At ART Fertility Clinics the cornerstone of their clinical practice is ethics and transparency. They have published package rates for various medical conditions and adhere to them strictly. For all recommended treatments and tests there is a documented medical requirement. Patient and billing records are provided in all instances. No superfluous testing or procedures are recommended or undertaken at any of their clinics.

*Compassionate & Caring Nursing Staff and Counsellors – Their Nursing staff and Counsellors are trained to understand the needs and requirements of their patients and ensure that treatment plans and options are explained clearly to them. They are available around the clock to provide medical services like medications, answer questions, and provide support.

*The Most Comprehensive Range of Services, Including Diagnosing Female and Male Infertility and Genetic Testing – “At ART Fertility Clinics, we provide the most comprehensive range of services to cover all the requirements at a Fertility clinic, including in-house blood lab, consultations, and Ultrasound imaging, embryology lab, OR and recovery, Genetic testing, and counseling. Our physicians are trained and qualified to diagnose and treat male infertility, including undertaking FNA, TESE, and Micro TESE,” says Dr Somesh.

Ace of ART

Dr Somesh Mittal has diverse experience of over 25 years in healthcare as a leadership expert who has been instrumental in transforming multi-national companies’ businesses, development, and outcomes. Previously, Dr Somesh worked as the Director of Operations for Sheares Healthcare, a Temasek subsidiary. He played a key role in Multiples Equity for the hospital vertical, wherein he managed Vikram Hospital to make it profitably incremental and is now owned by Manipal Hospitals. His experience also includes turning around more than ten Fortis Escorts centers in India and abroad. A major milestone in his career was the launch of Fortis Gurgaon as its Program Director.

Concerning his clinical role, Dr Somesh is an Oncologist trained at Rajiv Gandhi Cancer Institute and has practiced as a Consultant for several years at various acclaimed hospitals. He is also an alumnus of the University of Delhi’s Faculty of Management Studies. He holds a certificate from the University of Berkeley-Haas in Disruptive Innovations and has cleared Chartered Financial Analyst (CFA) Level-1, which has been fundamental in amalgamating his clinical and business backgrounds.

With his expertise in business strategy and planning for growth and operational excellence, Dr Somesh delivers exceptional top-line and bottom-line results while adhering to strict standards and quality. His entire career has been providing outstanding turn-around phases for organizations with a vision to succeed in their space. Dr Somesh has consistently played a significant role in achieving goals with his strategic mindset.

As Chief Executive Officer of ART Fertility Clinics for India, Dr Somesh strongly believes in bringing global standards of expert care and technology to the Indian Healthcare space with assisted reproduction and technology. ART Fertility Clinics is presently seven clinics strong in India and has four clinics in the Middle East. Dr Somesh is highly motivated to take the company to new heights and expand geographically in the coming years.


According to Dr Somesh, Artificial intelligence (AI) is gaining popularity because it has the potential to enhance medical outcomes. IVF success will significantly rise because of implementing AI within the fertility clinic.

This is because the current AI-based method of separating good-quality embryos from defective ones is anticipated to save embryologists time and effort. In turn, this might enhance the effectiveness of assisted reproduction technology (ART), the success rate of pregnancies, the range of available treatments, and patient care for infertility.

AI also supports IVF treatment during the cryopreservation or egg-freezing procedure, in addition to predicting the viability of embryos.

“We at ART fertility clinics are at par with the modern innovations in medicine. We have world-renowned embryologists and IVF specialists working in cutting-edge facilities to deploy the most advanced infrastructure and technologies,” reveals Dr Somesh.  

He also adds that they have a very wide science and innovation program wherein their clinicians use Artificial Intelligence to analyze medical data and define treatments based on empirical findings. He reiterates, “We currently have forty-one (41) areas of active investigative research that utilize the latest NGS system.”

Regarding challenges, Dr Somesh says that he believes healthcare service providers need to learn and unlearn the right and ideal medical practices that are suited and customized to patients’ needs. “Acceptance of issues is imperative, and I encourage transparency, trust building, and empathizing because these are the solution to every challenge one faces.” To ensure that these factors are adhered to stringently, onboarding the right leadership and talent can sometimes be challenging. However, if you diligently perform this task, growth can never stop.  

For budding entrepreneurs, “I advise emphasizing clinical outcomes.” To ensure the best outcome, you need to make sure that you follow the right processes. Transparency is the key to developing trust with your patients and improving the results greatly. Invest time in creating the highest standards for your team to adhere in maintaining patient protocols and ethical standards.

For the future, “Our vision is to expand to 24-30 clinics in India and adjoining countries within two years. Along with our presence in the Middle East and Europe, we also envision expanding in South-East Asia, such as Nepal, Bangladesh, and Myanmar,” he concludes.

Related Posts